Pricing
Login
Home
Charts
Search
Watchlist
Products

Bafna Pharmaceuticals Ltd

BAFNAPH
₹469.95-1.99%20 Nov 2026
Reports
Pharma Formulations

Bafna Pharmaceuticals Ltd

BAFNAPH
₹469.95
-1.99%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,112Cr
Close
Close Price
₹469.95
Industry
Industry
Pharma Formulations
PE
Price To Earnings
96.70
PS
Price To Sales
7.18
Revenue
Revenue
₹155Cr
Rev Gr TTM
Revenue Growth TTM
8.74%
PAT Gr TTM
PAT Growth TTM
31.36%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
284133403339353538422748
Growth YoY
Revenue Growth YoY%
-16.9-2.0-20.6-0.916.7-5.74.0-12.015.48.1-23.234.4
Expenses
ExpensesCr
313932373036303135392639
Operating Profit
Operating ProfitCr
-231433543419
OPM
OPM%
-7.37.03.69.49.38.014.612.18.08.43.318.1
Other Income
Other IncomeCr
11010-1111221
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
111220112222
PBT
PBTCr
-31-1311332307
Tax
TaxCr
000000000000
PAT
PATCr
-31-1311332307
Growth YoY
PAT Growth YoY%
-198.0-72.8-111.35.7132.3-10.3570.819.193.7109.9-97.6119.5
NPM
NPM%
-10.33.5-2.26.52.93.49.88.84.86.50.314.4
EPS
EPS₹
-1.20.6-0.31.10.40.61.41.30.81.20.02.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
284133403339353538422748
Growth YoY
Revenue Growth YoY%
-16.9-2.0-20.6-0.916.7-5.74.0-12.015.48.1-23.234.4
Expenses
ExpensesCr
313932373036303135392639
Operating Profit
Operating ProfitCr
-231433543419
OPM
OPM%
-7.37.03.69.49.38.014.612.18.08.43.318.1
Other Income
Other IncomeCr
11010-1111221
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
111220112222
PBT
PBTCr
-31-1311332307
Tax
TaxCr
000000000000
PAT
PATCr
-31-1311332307
Growth YoY
PAT Growth YoY%
-198.0-72.8-111.35.7132.3-10.3570.819.193.7109.9-97.6119.5
NPM
NPM%
-10.33.5-2.26.52.93.49.88.84.86.50.314.4
EPS
EPS₹
-1.20.6-0.31.10.40.61.41.30.81.20.02.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
85654744427185115152146151155
Growth
Revenue Growth%
-15.9-23.9-27.4-7.5-2.667.719.635.532.2-4.33.38.7
Expenses
ExpensesCr
83708257416173100141135135139
Operating Profit
Operating ProfitCr
3-5-35-13110121611111616
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.610.4
Other Income
Other IncomeCr
1131001034156
Interest Expense
Interest ExpenseCr
12117201122344
Depreciation
DepreciationCr
444334555567
PBT
PBTCr
-13-19-14-18-26512741111
Tax
TaxCr
0-12200000000
PAT
PATCr
-12-18-16-20-26511741112
Growth
PAT Growth%
-299.5-51.610.9-19.990.5410.3-10.5117.4-35.2-43.5167.331.4
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.47.4
EPS
EPS₹
-6.5-9.9-7.0-8.3-106.52.52.24.83.11.84.74.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
85654744427185115152146151155
Growth
Revenue Growth%
-15.9-23.9-27.4-7.5-2.667.719.635.532.2-4.33.38.7
Expenses
ExpensesCr
83708257416173100141135135139
Operating Profit
Operating ProfitCr
3-5-35-13110121611111616
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.610.4
Other Income
Other IncomeCr
1131001034156
Interest Expense
Interest ExpenseCr
12117201122344
Depreciation
DepreciationCr
444334555567
PBT
PBTCr
-13-19-14-18-26512741111
Tax
TaxCr
0-12200000000
PAT
PATCr
-12-18-16-20-26511741112
Growth
PAT Growth%
-299.5-51.610.9-19.990.5410.3-10.5117.4-35.2-43.5167.331.4
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.47.4
EPS
EPS₹
-6.5-9.9-7.0-8.3-106.52.52.24.83.11.84.74.9
Sales CAGR
1 Year3%
3 Years9%
5 Years16%
TTM9%
EBITDA CAGR
1 Year43%
3 Years0%
5 Years9%
TTM4%
PAT CAGR
1 Year167%
3 Years-1%
5 Years14%
TTM31%
Avg. ROCE
1 Year11%
3 Years9%
5 Years10%
TTM11%
CFO / EBITDA
1 Year96%
3 Years123%
5 Years94%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
19192424224242424242424
Reserves
ReservesCr
412217-3-733385057617280
Current Liabilities
Current LiabilitiesCr
878159711724224654525771
Non Current Liabilities
Non Current LiabilitiesCr
394228293561013162218
Total Liabilities
Total LiabilitiesCr
185167128121718690130148153176193
Current Assets
Current AssetsCr
11977484836505187948590102
Non Current Assets
Non Current AssetsCr
669079723537394254688691
Total Assets
Total AssetsCr
185167128121718690130148153176193
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
19192424224242424242424
Reserves
ReservesCr
412217-3-733385057617280
Current Liabilities
Current LiabilitiesCr
878159711724224654525771
Non Current Liabilities
Non Current LiabilitiesCr
394228293561013162218
Total Liabilities
Total LiabilitiesCr
185167128121718690130148153176193
Current Assets
Current AssetsCr
11977484836505187948590102
Non Current Assets
Non Current AssetsCr
669079723537394254688691
Total Assets
Total AssetsCr
185167128121718690130148153176193

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-314-7-1-34-1410592215
Investing Cash Flow
Investing Cash FlowCr
-1-838433-5-7-7-15-21-22
Financing Cash Flow
Financing Cash FlowCr
4-5-31-2712-510-116
Net Cash Flow
Net Cash FlowCr
00006-7-28-62-1
Free Cash Flow
Free Cash FlowCr
-52040-1-36-202-2-60-10
CFO To PAT
CFO To PAT%
24.4-74.243.15.51,824.7-233.6186.543.7129.1533.1138.5
CFO To EBITDA
CFO To EBITDA%
-105.5-262.520.28.4-2,788.7-132.281.331.585.4198.196.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-314-7-1-34-1410592215
Investing Cash Flow
Investing Cash FlowCr
-1-838433-5-7-7-15-21-22
Financing Cash Flow
Financing Cash FlowCr
4-5-31-2712-510-116
Net Cash Flow
Net Cash FlowCr
00006-7-28-62-1
Free Cash Flow
Free Cash FlowCr
-52040-1-36-202-2-60-10
CFO To PAT
CFO To PAT%
24.4-74.243.15.51,824.7-233.6186.543.7129.1533.1138.5
CFO To EBITDA
CFO To EBITDA%
-105.5-262.520.28.4-2,788.7-132.281.331.585.4198.196.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5655662623253001961811772671,112
Price To Earnings
Price To Earnings
55.857.517.324.642.624.196.7
Price To Sales
Price To Sales
0.70.81.40.60.14.63.51.71.21.21.87.2
Price To Book
Price To Book
0.91.41.61.3-0.55.74.82.72.22.12.810.8
EV To EBITDA
EV To EBITDA
47.4-25.9-3.1-5.3-2.732.926.013.418.418.119.071.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.511.67.020.535.935.339.633.429.729.231.931.9
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.610.4
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.47.4
ROCE
ROCE%
0.0-6.5-8.6-24.0128.09.18.214.29.26.110.910.9
ROE
ROE%
-20.5-45.1-40.6-94.942.610.38.415.49.14.911.511.2
ROA
ROA%
-6.6-11.1-12.9-16.4-2.66.75.88.85.02.76.36.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5655662623253001961811772671,112
Price To Earnings
Price To Earnings
55.857.517.324.642.624.196.7
Price To Sales
Price To Sales
0.70.81.40.60.14.63.51.71.21.21.87.2
Price To Book
Price To Book
0.91.41.61.3-0.55.74.82.72.22.12.810.8
EV To EBITDA
EV To EBITDA
47.4-25.9-3.1-5.3-2.732.926.013.418.418.119.071.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.511.67.020.535.935.339.633.429.729.231.931.9
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.610.4
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.47.4
ROCE
ROCE%
0.0-6.5-8.6-24.0128.09.18.214.29.26.110.910.9
ROE
ROE%
-20.5-45.1-40.6-94.942.610.38.415.49.14.911.511.2
ROA
ROA%
-6.6-11.1-12.9-16.4-2.66.75.88.85.02.76.36.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,4821,4031,3821,1121,0791,025874
Close PriceClose₹512.65584.85209.27469.95320.15511.9094.87
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.8724.4330.6496.7052.8310.5817.25
Price To SalesPS2.803.654.607.181.641.422.54
RevenueRevenueCr529385301155656722343
Revenue Growth TTMRev Gr TTM%12.6%38.4%6.4%8.7%14.3%14.3%0.7%
PAT Growth TTMPAT Gr TTM%1.0%64.2%-26.6%31.4%-55.0%21.1%287.7%
Market CapitalizationMkt CapCr1,4821,4031,3821,1121,0791,025874
Close PriceClose₹512.65584.85209.27469.95320.15511.9094.87
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.8724.4330.6496.7052.8310.5817.25
Price To SalesPS2.803.654.607.181.641.422.54
RevenueRevenueCr529385301155656722343
Revenue Growth TTMRev Gr TTM%12.6%38.4%6.4%8.7%14.3%14.3%0.7%
PAT Growth TTMPAT Gr TTM%1.0%64.2%-26.6%31.4%-55.0%21.1%287.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews